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ABSTRACT
Health impact assessment (HIA) focuses on minimizing inequities when studying the effects 
of a policy on the population’s health. Nevertheless, it is seldom simultaneously quantified, 
multivariate, and visually graphically comprehensible for non-statisticians. This paper aims 
to address that gap, assessing a policy promoting the quality of Electronic Health Records, 
linking hospital and primary health care data (Blood Pressure, Cholesterol, Triglycerides, 
Waist Circumference, Body Mass Index) to mortality outcomes and regional inequities. 
Acute Myocardial Infarction patients admitted in the hospital are then followed regularly in 
Portuguese NHS Primary Care. Regional disparities regarding recorded information are observed 
and different association patterns with mortality identified, ranked, and visualized through 
adjusted ORs for sex, age, and indicators of severity of hospital admission, complemented with 
multivariate correspondence analysis. A pathway to handling equity within quantitative HIA 
shows that complexity in data and methods may generate simplicity and clarity through visual 
graphical aids. Tackling Big Data with Data Science in HIA may even be at the center of future 
health reforms, assessing impacts of health promotion and chronic disease policies.
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Health impact assessment (HIA) was earlier defined as a 
‘combination of procedures, methods and tools by which 
a policy, program or project may be judged as to its poten-
tial effects on the health of a population and the distri-
bution of effects within the population’ (European Centre 
for Health Policy 1999). The International Association for 
Impact Assessment (IAIA) added that ‘HIA identifies appro-
priate action to manage those effects’ (i.e. the effects on 
health and distribution of health)’ (Quigley et al. 2006).
HIA thus identifies paths between a policy, program, or 
project and positive and negative externalities induced 
on health determinants (individual, social, and environ-
mental factors, including institutional factors), estimat-
ing its unintended, often unexpected, health outcomes. 
It is at its core a decision support tool, to inform and 
influence decision-makers into improving a proposal for 
health and equity, maximizing positive health impacts 
and minimizing negative ones throughout a population 
(Quigley et al. 2006; Kemm 2013).
HIA is regularly being used in many countries such 
as the UK, the Netherlands, Australia, New Zealand, 
Thailand, the USA, and others, more often with a quali-
tative emphasis (Kemm 2013; World Health Organization 
2015). Quantifying health estimations within HIA was 
however very early in HIA history identified as potentially 
more informative and influential with decision-makers 
(Mindell et al. 2001; Kemm 2013), complementing qual-
itative analyses to achieve more robust, evidence-based 
and whole estimations of health impacts that would 
include the nature of these impacts, as well as their direc-
tion, magnitude, and distribution.
Nevertheless, it has been recognized that quantifica-
tion within HIA is rarely done, since it ‘is often hard or 
impossible’ because of a lack of information regarding 
initial conditions, effects of the proposal, and the theo-
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(PC) data, pharmaceutical drugs consumption and pre-
scription, as well as the mortality registry. As far as we 
know, it was the first time researchers in Portugal were 
able to get these kind of data and various procedures 
had to be taken to safeguard the anonymity of patients 
and their rights.
Aims
Our aims in this paper are:
(1)  To show how to identify and visualize regional 
disparities in a quantified way when applying 
an Electronic Health Records (EHR) policy tar-
geted for HIA;
(2)  To study associations between mortality of 
acute myocardial infarction (AMI) patients and 
an EHR policy targeted for HIA, while identify-
ing potential regional inequities, in a multivari-
ate yet simple way to visualize;
(3)  To propose a conceptual quantitative path of 
analysis for HIA to study associations between 
equity, health impacts and policies, based on 
Data Science and Data Mining methods applied 
in a Big Data context.
Materials and methods
Strategy
To put our strategy into practice, we take:
•  As sample, all adults admitted to hospitals for AMI 
during the second semester of 2012, followed reg-
ularly in PC during 2013, always within the NHS in 
Portugal;
•  As a policy targeted for HIA, an EHR program to 
promote registration of information at PC level 
regarding the indicators blood pressure, choles-
terol, triglycerides, waist circumference, and body 
mass index (BMI);
•  As health impact of interest, the mortality status at 
the end of the period of study, running from after 
hospital admission during the second semester of 
2012 until 31 December 2013;
•  As an equity aspect under scrutiny, regional dis-
parities in Portugal, since not assuring an adequate 
application of the policy throughout all five health 
regions of residence (Norte, Centro, LVT-Lisboa e 
Vale do Tejo, Alentejo and Algarve) may contribute 
to regional health inequities.
To reach our first aim, we start by identifying associations 
between the EHR policy and regions: regions are ranked 
according to the strength of their association with infor-
mation registered and then these associations are visu-
alized graphically to ease interpretation.
Generally, two different approaches to HIA quantifi-
cation have been followed, one based on health eco-
nomic evaluation and another on risk assessment (Fehr 
et al. 2012). Quantified HIA based on health economic 
evaluation relies on health technology assessment 
methods, estimating indirect costs and health-related 
quality of life indicators (Brodin and Hodge 2008) and 
dealing with equity for instance by applying weights to 
account for inequalities when calculating health gains 
or by estimating health benefits separately by relevant 
population subgroups (Glover and Henderson 2010). The 
HIA quantification based on risk assessment is grounded 
in environmental and public health research experience 
of estimating risk exposure, frequently relying on epide-
miology modeling (Fehr et al. 2012; Kemm 2013). Other 
HIA-related quantification experiences include profiling 
individuals, screening policies, (Bacelar-Nicolau et al. 
2008, 2015a, 2015b) and evaluating HIA effectiveness 
(Harris-Roxas et al. 2012, 2014; Haigh et al. 2015).
An assortment of computational tools for HIA quan-
tification has been made available: some more generic, 
others more specific to certain determinants or dis-
eases; some more related to environmental health risk 
assessments, others more in tune with public health risk 
factor-outcome modeling; most not very user-friendly 
without support from the original developers. Further 
tool development is no longer considered a priority, 
but improvements are needed regarding two aspects: 
its application in various real-life contexts and especially 
in ‘whether and how they estimate impacts on health 
inequalities’ (Fehr et al. 2012, 2016).
The fact is that HIA still quite seldom uses multivari-
ate statistical methods to estimate health impacts while 
taking equity into account and providing easy-to-under-
stand visual outputs (Veerman et al. 2005).
Among the difficulties, a major one is to find availa-
ble and reliable data to model interrelations, explicitly 
between health determinants, health impacts, policies 
and related costs (Fehr et al. 2012, 2016; Harris-Roxas et 
al. 2012). Another barrier is that complex statistical meth-
odologies used frequently generate results difficult to 
understand by non-statisticians, including decision-mak-
ers (Fehr et al. 2012).
Our approach focuses precisely on how to overcome 
these difficulties and improve quantified HIA by showing 
how one may take into account equity while applying 
multivariate methodologies usually used in a data min-
ing, big data context: complex but with clear graphical 
representations of results.
We were given access to a database linking several data 
origins – data source SPMS/ACSS (Serviços Partilhados do 
Ministério da Saúde/Administração Central do Sistema 
de Saúde) – as a pilot project to investigate how enrich-
ing it could be to have information on individual patients 
linking data from the Portuguese National Health Service 
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To attain our second aim, associations between 
information registration and mortality are assessed 
within each region; regions are then ordered by the 
strength of these associations, and these connec-
tions are finally visualized graphically to simplify 
interpretation.
Lastly, to reach our third aim, inspired on the path 
followed in our case study regarding goals above, a con-
ceptual framework is proposed to analyze associations 
between policies and health impacts while considering 
equity, in a quantified multivariate way, when undertak-
ing HIA.
Data
Data consist of information on all adults (≥20 years old) 
admitted in Portuguese NHS Hospitals with AMI diag-
nosis during the second semester of 2012 and followed 
in the NHS PC network regularly during 2013 (over 
two quarters with appointments with a general practi-
tioner) – data source SPMS/ACSS (Serviços Partilhados do 
Ministério da Saúde/Administração Central do Sistema 
de Saúde). Patients with no resuscitation or with only 
comfort measures information or who were discharged 
against medical opinion were excluded. A total of 3,776 
cases were considered for analysis.
Variables for analysis included:
•  Mortality outcome under study: being deceased or 
not at 31 December 2013;
•  Four indicators regarding having information 
registered or not: blood pressure, cholesterol, 
triglycerides, waist circumference, BMI. BMI was 
either existent in the database or was calculated 
whenever values for weight and height were both 
available;
•  Five health regions of residence: Norte, Centro, 
LVT, Alentejo and Algarve;
•  Demographic variables: sex and age;
•  Four hospital admission severity variables: having 
one or more hospital readmissions during the sec-
ond semester of 2012 also for AMI diagnosis, hav-
ing undertaken surgery during hospital admission, 
having mean admission duration over six days, 
having six or more diagnoses associated with hos-
pital admission.
Note that the inclusion criterion of being followed in 
the NHS PC network regularly during 2013, guaran-
teeing that each patient has at least three quarters 
with appointments with a general practitioner, means 
assuring that each patient has had the same oppor-
tunity of having information registered about their 
condition. Any patient within the study has accord-
ingly had appointments with a general practitioner, 
even if he or she has died during the follow-up period 
of 2013.
Statistical methodologies
Statistical methodologies differ depending on the stage 
of the study undertaken. In the first stage, associations 
between registering or not registering indicators (blood 
pressure, cholesterol, triglycerides, waist circumfer-
ence, BMI) and regions (Norte, Centro, LVT, Alentejo and 
Algarve) were regarded, and in the second stage asso-
ciations between mortality and registering or not reg-
istering indicators stratified by region were considered.
At each stage, a bivariate approach was first under-
taken with contingency tables, independence χ2 or 
Fisher exact tests (Daniel 2009), followed by a multivar-
iate approach based on logistic regression with Odds 
Ratios (Kleinbaum and Klein 2010), crude and adjusted 
after controlling for sex, age, and sex and age inter-
action. In the first stage overall and adjusted OR were 
also calculated controlling for region. Results presented 
in this paper mainly focus on models with Algarve as 
reference region, although models with other regions 
as references were estimated to identify significant dif-
ferences between regions. In the second stage, logistic 
models were additionally adjusted for hospital admission 
severity indicators and stratified by region.
Finally, multivariate exploratory data analysis meth-
ods were used, specifically principal components anal-
ysis over the OR table (indicators versus regions – SOM 
Table 4) in the first stage and multivariate correspond-
ence analysis over the initial database (Hair et al. 2006; 
Saporta 2011).
Statistical analyses were generally conducted with 
IBM-SPSS version 22 software. A significance level of 5% 
was used whenever statistical tests were applied.
Further detailed information on statistical analy-
ses undertaken and results obtained may be found in 
Supplemental Online Material (SOM).
Results
Associating regions to health indicator 
registration
In this first stage, with our first aim in mind, we start by 
studying associations between regions and the registra-
tion or not of certain health indicators.
Bivariate analyses show that registering information 
on each indicator at PC level is not uniform throughout 
all health regions of residence of patients under study 
(SOM Table 1 and Figure 6). Algarve, closely followed by 
LVT, is the region with the highest percentage of no-reg-
istration for every indicator in the study. Norte, usually 
followed by Algarve, is the region with the lowest per-
centage of no-registration for every indicator. Centro 
usually appears between values of these two subgroups. 
Blood Pressure presents the highest registration rates, 
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When comparing indicators over the various regions 
(Figure 1 and SOM Table 2), Waist Circumference per-
forms better in Norte and Centro, while other indicators 
do not perform very differently over various regions. 
Nevertheless, Blood Pressure still tends to present higher 
OR and BMI often appears with worse performance than 
other indicators, namely in Centro and Alentejo.
Within each region, patterns of registration for indi-
cators may in reality not differ very much, since 95% 
confidence intervals (CI95%) overlap (SOM Tables 2 and 
3 and Figure 7). Disparities become clearer when com-
paring CI95% for OR between regions (SOM Figure 8). 
Thus, CI95% related with every indicator for Norte and 
LVT never overlap, which means Norte is clearly very 
different both from LVT and Algarve. LVT presents the 
smallest CI95% range for all indicators, which may be 
associated with a more uniform practice of registering 
information. Waist Circumference displays the highest 
CI95% range, which may be related to its higher percent-
ages of no registration of information (percentages of no 
registration between 74% of Norte and more than 92% 
of LVT, against values always below 56% for Norte and 
below 78% for other regions).
Adjusted OR results (SOM Table 4) are then taken as 
input data for Principal Components Analysis which 
summarizes previous findings, again in a very visual way.
The first principal component responsible for almost 
all variability contained within data (94%) represents 
Adjusted logistic regression models show Norte 
with the strongest association with registration for all 
health indicators and significantly different from all 
other regions, excepting Alentejo for Blood Pressure 
and Triglycerides (Figure 1 and SOM Tables 2 and 3). 
Norte displays adjusted OR always above 2, being thus 
more than twice as likely to have values registered than 
Algarve (the reference region, usually with worse reg-
istration rates regarding the indicators under study). 
The minimum Norte OR of 2.7 for Triglycerides is always 
higher to the maximum OR of all other regions for all 
other indicators. Norte mostly differs from other regions 
regarding Waist Circumference registration.
Alentejo and Centro usually follow Norte as the most 
associated with registration and are only significantly 
different from each other for Blood Pressure, for which 
Alentejo draws up to Norte. Alentejo is usually always a 
little more associated with registration than Centro and 
is only overcome by Centro for Waist Circumference, 
although not enough to be statistically significant. 
Alentejo records OR over 2 for all indicators but BMI, 
which displays a lower value, whereas Centro only pre-
sents an OR over 2 for Waist Circumference.
LVT and Algarve are the regions less associated with 
registration, LVT presenting OR always below 2 for all 
indicators. LVT is only significantly different from Algarve 
for Blood Pressure, although with a small OR of 1.370 
(Figure 1 and SOM Tables 2 and 3).
Figure 1. association between registration of each health indicators and health regions of residence – adjusted or.
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associating outcome mortality as of 31 December 2013 
and having information registered at PC level for each 
of the indicators – blood pressure, cholesterol, triglyc-
erides, waist circumference, and BMI (SOM Tables 5 to 
9). Deceased patients always present higher rates of no 
information registered: 53% of deceased patients do not 
have Blood Pressure recorded (versus 34% of patients 
alive at the end of follow-up), 84% BMI recorded (ver-
sus 63%), 91% Triglycerides recorded (versus 65%), 
89% Cholesterol recorded (versus 65%), and 92% Waist 
Circumference recorded (versus 83%). Note that all 
patients studied, deceased or not, had several general 
practitioner appointments within the follow-up period 
and so have had an opportunity of having information 
recorded.
When considering each region separately, deceased 
patients also always present higher rates of no informa-
tion registered for all health indicators (SOM Tables 5 to 
9). For some regions and indicators, this pattern is not 
statistically significant since the observed information 
is not enough to identify differences, even if they exist, 
essentially because of small sample sizes for certain cate-
gories. In Norte, deceased patients always present a sta-
tistically significant higher percentage of no registration 
for all health indicators. In Centro and LVT the same hap-
pens, with the exception of Waist Circumference (SOM 
Table 8). In Alentejo, deceased patients present signif-
icantly higher percentages of no registration for Waist 
Circumference and BMI (SOM Tables 8 and 9, respec-
tively). Finally, in Algarve deceased patients present a 
a size effect axis of registration of information, with all 
indicator variables placed in the far right of the factorial 
plan (Figure 2).
Regions toward the right in the factorial plan will then 
be associated with higher rates of registered information 
regarding all these indicator variables. Inversely, regions 
toward the left in the factorial plan will be associated 
with lower rates of registered information concerning 
the indicator variables. One may hence rank regions from 
the most effective registering information, at the far right 
side of the factorial plan, to the least effective, at the left-
end side. Sequentially, one visually ranks Norte (unmis-
takably detached toward the right), Alentejo, Centro and 
then LVT and Algarve.
Stage 1 results clearly indicate there are indeed dif-
ferences among regions concerning patterns of regis-
tration of health indicators under study, confirming the 
relevancy of proceeding with Stage 2.
Associating health indicator registration and 
mortality by region
Since a relevant association is found between recording 
information on health indicator policy and the equity 
aspect under study in Stage 1, now with our second 
research aim in mind, we go onward to study associa-
tions between mortality and registration of the various 
health indicators within each region.
When taking the sample as a whole, the initial bivar-
iate approach identifies statistically significant results 
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The highest association between mortality and no 
registration in LVT concerns Triglycerides (OR of 3.467). 
Most OR values in LVT are observed between 2.3 and 2.5, 
concerning BMI, Cholesterol, and Waist Circumference.
Algarve only displays information for BMI and Blood 
Pressure at quite high levels of association (3.835 and 
2.945, respectively).
As regards the precision of the estimated OR, CI95% 
within each region always overlaps (SOM Tables 10 to 14 
and SOM Figures 9 and 10), but there are certainly dif-
ferences regarding regions, especially in what concerns 
the range of CI95%. Lack of information, due essentially 
to small sample sizes, observed in certain regions and 
indicators, does not always make possible computing 
reliable CI95% and in some cases creates asymmetries 
regarding the higher limit of intervals. Therefore, only the 
lower limit and its distance to the 1 threshold will be ana-
lyzed, especially in what concerns Algarve for Blood pres-
sure and BMI, Alentejo for BMI and Norte for Cholesterol 
and Triglycerides. When comparing CI95% for OR within 
each indicator (SOM Figure 9), one may observe that 
lower limits for Norte are more distant from value 1 than 
all other regions for all indicators, with the exception of 
Waist circumference (lower limit of 1.076, while all others 
for Norte are above 1.9). Algarve has a much wider CI95% 
than other regions. For Cholesterol and Triglycerides, it is 
Norte that stands out and for BMI Alentejo and Algarve. 
When comparing CI95% for OR within each region (SOM 
Figure 10), Norte presents quite narrow intervals, apart 
from the ones already mentioned for Cholesterol and 
Triglycerides. Alentejo presents a very wide CI95% for 
BMI, but quite narrow for the other indicators. Centro and 
LVT are quite stable in the precision of CI95% for all indi-
cators, perhaps slightly wider for Triglycerides. Algarve 
has quite wide IC95% for Blood pressure and BMI, the 
only indicators with available OR in this region.
Finally, multiple correspondence analysis (MCA) is 
used complementarily to help summarize findings, 
especially taking advantage of its rich visual graphical 
aids (Figure 4).
MCA identifies two main dimensions of variability 
within the data: a health indicator registration dimension 
and a demographic/hospital admission characterization 
dimension.
Dimension 1 represented on the horizontal axis of 
the factorial plan is a dimension of indicator registra-
tion. Categories toward the right in the plan are more 
related to no registration, while categories toward the 
left are more concerned with registration. In the regis-
tration quadrants of the plan, one also finds Norte, while 
in the non-registration quadrants, one finds Algarve and 
LVT. Alentejo and especially Centro position themselves 
within a neutral area, near the origin.
Dimension 2 represented in the vertical axis of the fac-
torial plan concerns characteristics used as adjustment 
variables when calculating OR previously, namely Age, 
Sex, and the four hospital admission severity indicators 
significantly higher percentage of no registration for 
Triglycerides (SOM Table 7).
When considering overall models without regional 
stratification, estimated OR with and without adjust-
ments for age, sex, and severity indicators seem quite 
similar (SOM Tables 10 to 14). Hence, these adjustment 
variables do not appear very relevant when studying 
overall associations between mortality and registration.
Additionally, all these OR obtained without regional 
stratification are statistically significant and always above 
a 2.00 threshold. That means that globally patients with-
out registered information are at least twice as likely to 
be deceased than patients with information registered.
The lowest values of OR are generally observed for 
Blood Pressure (between 2.149 regarding the setup 
adjusted for Sex, Age, and Sex*Age to 2.417 concern-
ing the setup controlled for Sex, Age, Sex*Age, the four 
admission severity indicators, and region – SOM Table 
10). The highest values of OR are generally observed 
for Triglycerides (between 4.926 regarding the setup 
adjusted for Sex, Age, and Sex*Age to 5.905 concerning 
the setup controlled only for Region – SOM Table 12). 
Limits of CI95% generally follow these trends of OR, with 
a minimum of 1.376 of the CI95% (observed in the setup 
regarding Waist Circumference controlled for Sex, Age, 
and Sex*Age – SOM Table 13) and a maximum of 9.062 
(detected in the setup associated with Triglycerides con-
trolled for Region – SOM Table 12).
Stratified setups, however, display quite a few differ-
ences between regions and indicators, whether consid-
ering or not adjustments by age, sex, interaction age*sex, 
and hospital severity indicators (SOM Tables 10 to 14), 
showing the importance of controlling for these aspects. 
Consequently, stratified adjusted setups will henceforth 
be the focus of our analysis.
All computed associations between mortality and 
no registration for all indicators are strong, the lowest 
OR being found for Blood Pressure in LVT and Alentejo 
(1.932 and 1.773, respectively) – (Figure 3). This means 
that, at its lowest, AMI patients with no Blood Pressure 
registered in Alentejo are about 1.8 times more likely to 
be deceased than patients with information registered.
Norte sets off as having the highest OR for Cholesterol 
and Triglycerides (both above 13). This means that 
patients without registered information for Cholesterol 
and Triglycerides in Norte are about over 13 times more 
likely to be deceased than patients with information reg-
istered. Norte also displays strong associations between 
mortality and no registration for Blood Pressure and BMI 
(OR between 3 and 4).
Alentejo stands out concerning BMI, with an OR near 
7, followed by Triglycerides and Cholesterol with lower 
OR between 2 and 3.
Centro presents high OR values, especially regarding 
Triglycerides and Cholesterol (4.409 and 3.173, respec-
tively), followed by BMI, Waist Circumference, and Blood 
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registration of indicators and, on the other hand and 
understandably, with a more complex clinical condi-
tion and advanced age. The deceased outcome comes 
out as more associated with LVT and Algarve and less 
with Norte. Alentejo seems to lean slightly toward the 
deceased outcome, but more in what concerns the 
demographic and hospital admission severity charac-
teristics and not regarding registration on a number 
of indicators (due to its location near the vertical axis 
origin).
Consequently, there are indeed differences among 
regions in their association patterns regarding mortality 
and registration of the health indicators under study. The 
methodologies used lead us to different ways of visualiz-
ing information and grasping diversity in results.
(having one or more hospital readmissions during the 
second semester of 2012, having undertaken surgery 
during hospital admission, having a mean admission 
duration over six days, having a hospital admission with 
six or more diagnosis associated). In the upper quad-
rants, one often finds patients that are female, older 
(more than 70 years old), longer admissions (more than 
seven days), with no surgery during admission, and with 
more than five diagnoses. In the lower quadrants, one 
finds patients that are frequently male, younger (70 years 
or less), with five or fewer diagnoses, have undertaken 
surgery, with readmissions, and with shorter admissions 
(seven days or less).
The deceased outcome is displayed in the right upper 
quadrant, thus associated, on the one hand, with no 
Figure 3. association between mortality and registration of each health indicator stratified by health region of residence – adjusted 
or.
notes: (1) after controlling for sex, age, sex * age and hospital administration severity indicators; (2) stratified models by region; not applicable for waist 
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may contribute to putting HIA at the center of future 
health care reforms.
Implications of EHR policies applied unevenly 
throughout the regions
Differences in health information registration between 
regions observed at Stage 1 of result section indicate an 
uneven regional application of EHR policies.
At PC level, there may exist various ways of recording 
patients’ clinical information, from paper to alternative 
Discussion
We will discuss implications of an EHR policy being 
applied unevenly throughout regions regarding data 
quality and the policy itself, links between EHR and qual-
ity of health care and EHR relevance for disease preven-
tion, health promotion, and sustainability. We will then 
debate on our research-added value for HIA concerning 
AMI patients and visualization methods understandable 
by non-statisticians in a Big Data context. Finally, an HIA 
conceptual approach will be proposed to tackle equity, 
health impacts, and policies in a quantified way, which 
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and as a quality of care indicator (Majeed et al. 2008). 
Differences in health information registration between 
regions may thus indicate disparities on the quality of 
care supplied, and hence regional inequity issues to be 
improved upon.
Regional disparities regarding relevant associations 
between registration of various health indicators and 
mortality outcome found in results section may be mit-
igated with an effort to uniformly apply an EHR policy 
throughout hospital and primary care.
But although EHR are used as a quality of care indi-
cator, this does not immediately imply that EHR will 
directly contribute to a better health care provision. 
Both aspects may indeed be correlated without having 
a direct cause-effect. Health care providers that have effi-
ciency management concerns and are more recent and 
technologically advanced may have both EHR with more 
quality and better performance in supplying health care 
(Tanner et al. 2015).
Nevertheless, the existence and analysis of EHR may 
also directly contribute to better health at patient care 
level, helping clinicians collect and access information 
to improve their service (Burke et al. 2015).
For instance, a patient with many records registered 
may not necessarily have a better follow-up by PC 
health care, but many different records may imply many 
contacts with the PC health care network. This may in 
turn increase opportunities to identify problems, thus 
enhancing odds for ‘better health,’ promoting health and 
preventing disease. A consistent EHR policy throughout 
health regions may thus support an even implementa-
tion of programs such as NHS Health Checks introduced 
in England in 2010 to prevent heart disease, stroke, kid-
ney disease, and diabetes. It may also help evaluate 
these programs regarding increasing cardiovascular risk 
factor detection, reducing inequalities and monitoring 
trends of better detection of hypercholesterolemia, and, 
although to a lesser extent, obesity and hypertension 
(Forster et al. 2015).
EHR for disease prevention, health promotion, and 
sustainability
The existence of EHR that include or are linked to infor-
mation on social health determinants becomes espe-
cially pertinent when considering the WHO Health 2020 
framework (WHO Regional Office for Europe 2013) to 
promote sustainable and equitable improvements in 
health. Good health is no longer seen as an outcome of 
just one sector, the health sector, but as ‘the product of 
effective policy across all parts of government and col-
laborative efforts across all parts of society’. Good health 
is also acknowledged as essential for the improvement 
of the lives of single individuals, families, communities, 
ultimately as a benefit for all sectors and the whole of 
society.
electronic platforms, depending on the institution. However, 
in Portugal, specific information is regularly uploaded onto 
a platform to calculate health contratualization indicators, 
in which performance of health care providers may be 
evaluated. Contratualization indicator performance and 
evolution over time represent much of the basis for con-
tracts (re)negotiation, monitoring, and evaluation between 
Health Regions Administrations and PC providers of NHS 
(Departamento de Gestão e Financiamento de Prestações 
de Saúde da ACSS 2013b, 2014).
Indicators selected for our research – blood pressure, 
cholesterol, triglycerides, waist circumference – are cur-
rently used to calculate some of these contractualization 
indicators (Departamento de Gestão e Financiamento de 
Prestações de Saúde da ACSS 2013a, 2015).
For instance, the proportion of hypertensive patients 
with cardiovascular risk within three years, represent-
ing patients’ cardiovascular risk, is accessed through 
SCORE (Systematic Coronary Risk Evaluation) method-
ology, according to the General Directorate of Health 
guidelines under the National Health Plan of Cerebro-
cardiovascular Disease (Departamento da Qualidade 
na Saúde da Direção-Geral da Saúde 2013). European 
Guidelines on Cardiovascular Disease Prevention include 
among parameters to access SCORE cardiovascular level, 
all health indicators under analysis here – blood pressure, 
BMI, waist circumference, cholesterol level, and triglycer-
ides level (Perk et al. 2012; Piepoli et al. 2016).
These five chosen health indicators are essential to 
access cardiovascular risk and represent a direct incen-
tive to PC providers to assure information is recorded. 
One would hence expect that this information on which 
health care providers depend to be financed would dis-
play the highest registration performance among all 
recorded clinical information. The missing information 
problem identified throughout our research among 
these indicators may hence constitute an even worse 
issue regarding other kinds of data, eventually also rel-
evant to access patients’ health and monitoring.
Since a lack of records regarding patients with AMI 
diagnosis followed at PC seems first to concern all 
regions, a stronger implementation of EHR policy guide-
lines may be needed nationwide.
Additionally, since there are also regions where this 
lack of records is even more blatant, like Algarve or LVT, 
EHR policy guidelines and the way they are put into prac-
tice may need to be segmented and adapted to each 
region’s specificities.
But may regional disparities regarding EHR truly cor-
respond to regional equity issues? What is known regard-
ing links between EHR and quality of health care?
Links between EHR and quality of health care
The existence of national EHR at primary and hospital 
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In spite of some improvements in outcomes in CVD 
rates in many countries in Europe since the early 1980s, 
owing to preventive measures, especially regarding 
tobacco and smoking legislation, inequalities between 
countries persevere and many risk factors have even 
been accentuated, particularly obesity and diabetes 
mellitus (Piepoli et al. 2016).
The OECD estimates AMI-standardized death rates in 
2012 for Portugal of 47.4 and 34.4 per 100,000 male and 
female inhabitants, respectively (OECD—Organisation 
for Economic Co-operation and Development 2016). 
Values remain similar between 2013 and 2014 with 
47.3 and 34.2 per 100,000 male and female inhabitants, 
respectively. However, this represents a considerable 
decrease from 2008 rates of 59.8 and 43.0 per 100,000 
male and female inhabitants, respectively.
Information regarding AMI in Portugal indicates gen-
der and age differences as well as regional differences 
regarding hospital admissions – number of admissions, 
deaths in the hospital, length of stay, among others (Cruz 
Ferreira et al. 2016). However, no multivariate adjusted 
methods were applied here, and published tables are 
quite numerically dense, which impairs the perceiving 
of potential regional equities.
Our approach to use linked data at the patient level 
to generate multivariate results, controlled for sex, age, 
and severity hospital admission indicators constitutes 
an important evidence base for decision-makers to per-
ceive regional disparities and associations to mortality 
and EHR policies at PC level.
Observed different regional magnitudes of associa-
tions between AMI mortality and registration of distinct 
indicators may be related to diverse patterns of relevance 
regarding preventive and risk factors. To study reasons 
behind these disparities may constitute significant clues 
for the HIA to undertake, identifying distinct relevant 
regional lifestyles, other policies that interact with these, 
and so on. Being able to link additional information at 
the patient level (clinical, on social health determinants 
and policies) may thus be decisive toward increasing 
knowledge regarding equity issues for HIA. This becomes 
even more relevant when addressing chronic non-com-
municable diseases for which promotion and prevention 
policies are increasingly critical. Quality-linked databases 
monitored regularly at the patient level are essential to 
designing, implementing, and monitoring health and 
equity effects of public policies. To assess impacts of 
health promotion and chronic non-communicable dis-
ease prevention policies, Big Data will have to be tackled 
within a quantified HIA framework.
Challenges of Big Data and complexity in methods 
but simplicity in visualization
EHR may improve health at a secondary level, especially 
when clinical data is linked with additional informa-
tion regarding health and social health determinants, 
Assuring quality of EHR is moreover essential to 
empowering patients and citizens and thus improving 
health outcomes, health system performance and patient 
satisfaction by promoting and facilitating freedom of 
choice of PC units for NHS users (Mendes Ribeiro 2009; 
Mendes Ribeiro et al. 2011, 2015; OECD—Organisation 
for Economic Co-operation and Development 2017).
Guarantying the quality of EHR and their link to infor-
mation on the social determinants of health in a context 
of HIA is furthermore essential to answering a core ques-
tion for policy-makers: To what extent do investments 
in preventive actions addressing social determinants of 
health represent an efficient choice to help promote and 
protect the health of the population?
Evidence base from controlled trials and well-designed 
observational studies demonstrates the cost-effective-
ness of a wide range of interventions concerning health 
promotion and disease prevention that address risk fac-
tors to health: measures to reduce ‘risks of smoking and 
alcohol consumption, increase physical activity, promote 
more healthy diets, protect psychological and emotional 
well-being, reduce environmental harms and make road 
environments safer’ (Merkur et al. 2013). Quality data aid 
the evaluation of policies and actions taken, identifying 
those that are more cost-effective (such as taxes to influ-
ence individual choices of tobacco, alcohol, and food con-
sumption) and the ones less so (like media campaigns). 
However, there is still little data on the impact of inter-
ventions on health inequities, on appraising if a public 
health intervention has a higher or lower effect on cer-
tain groups in society inadvertently widening avoidable 
health inequalities. Methodologies used in our research 
could help deal with equity in this broader context.
Having data available, adopting and using EHR in 
a widespread manner and being able to study bigger 
cohorts through time linking data from various sources 
is most important to promoting equity, cost-effective-
ness (Asaria, Walker, et al. 2016; Asaria, Grasic, et al. 2016; 
Beresniak et al. 2016) and identifying determinants of 
where to act (Fehr et al. 2014), improving clinical care, pre-
venting disease, and promoting health (Hansell and Aylin 
2003; Mendes Ribeiro et al. 2015; OECD—Organisation 
for Economic Co-operation and Development 2017). This 
is especially pertinent considering the evolution of the 
burden of chronic non-communicable disease such as 
cerebrocardiovascular disease.
EHR and AMI
Cardiovascular disease (CVD) remains a leading cause 
of morbidity and mortality in Europe, causing over 1.9 
million deaths in the European Union (EU), amounting 
to 40% of all deaths in the EU. Overall, CVD is estimated 
to cost the EU economy almost €196 billion a year, 54% 
being due to health care costs, 24% to productivity 
losses, and 22% to the informal care of people with CVD 
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these equity issues in particular. We should yet reflect 
on the usefulness of undertaking an HIA, which has at 
its core equity concerns. Additionally, we should ponder 
on data selected and its quality since there could indeed 
exist alternative or complementary information, which 
better embodies the spirit of the policy, health outcomes, 
and equity aspects under study.
If a relevant association between policy and the 
health event of interest is found, then the association 
between policy and the health event of interest should 
be studied subject to equity aspects.
Then, if an association between the policy and the 
health event of interest is identified with differences 
among equity categories, then a contribution to HIA 
recommendations is potentially valuable to maximize 
positive health impacts and minimize negative ones 
while curtailing harmful inequities.
IAPA states that ‘HIA investigate the pathways of 
how the inter-related determinants may be affected 
by a proposed policy’ (Quigley et al. 2006). Following 
our recommended pathway, quantifying HIA using the 
added-value of big data and data science visualization 
tools may contribute to a more comprehensive way for 
decision-makers to understand HIA results and even to 
a wider HIA practice.
HIA and the future of health reforms
The ‘Next Generation of Health Reforms’ Statement 
was approved by OECD (Organization for Economic 
Co-operation and Development) health ministers on 
January 2017 (OECD—Organisation for Economic 
Co-operation and Development 2017). This new vision 
for the future includes reducing health inequalities in 
access to care and health outcomes, adapting health 
systems to new technologies and innovation and reori-
enting health systems to become more people-centered. 
All these challenges may be undertaken with a strong 
support from an HIA approach.
The equity-oriented HIA methodologies may con-
tribute to tackling barriers to the health literacy of the 
population, minimizing disparities in the ever-increas-
ing access of patients to growing amounts of infor-
mation, empowering them in the decision about their 
treatment.
The editor’s comment of WHO’s Eurohealth 2017 
Spring issue states that ‘there is a growing awareness 
that harnessing “big data’’, if done properly, could trans-
form both the quality of healthcare for patients and how 
health systems perform’ (Merkur et al. 2017). Linking 
databases by sharing EHR and integrating other non-
health care systems information sources (geographic 
location, socioeconomic status, lifestyle, and social net-
works) may support the transformation policy-makers’, 
patients’, and providers’ need toward a data-driven and 
value-based health care (Salcher 2017).
allowing for epidemiological and clinical research and 
health assessment of populations (Biro et al. 2016). Yet, 
this cannot be achieved without high-quality data and 
an adequate underlying digital infrastructure (Majeed et 
al. 2008; Lau et al. 2012; Barkhuysen et al. 2014).
The use of EHR, the higher capacity of storing and 
processing data and the need to assure that actions 
and policies are sustainable, cost-effective, maximiz-
ing positive health impacts, minimizing negative ones, 
and equity oriented, all have led to growing amounts of 
data at our disposal, generated at an ever-increasing and 
faster rate. Big Data in a health environment (that actu-
ally goes beyond the health sector per se, through social 
health determinants and other sectors) is an unavoida-
ble reality, as well as challenges of tackling information 
and finding new ways (or rediscovering and adapting 
old ones) of processing, analyzing, and communicating 
reliable evidence-based knowledge understandable by 
decision-makers. The new interdisciplinary field of Data 
Science has emerged, feeding on statistics, data mining 
and predictive analytics and whose activity ultimately 
culminates in data visualization (Donoho 2015).
Both complementary visualization approaches used 
in each of the result stages are based on multivariate 
methodologies, more usual in a data mining context 
than in an HIA epidemiological research. OR were first 
calculated to study adjusted associations between regis-
tering or not registering indicators and the region of res-
idence and then between registering or not registering 
indicators and mortality while accounting for regional 
equity. The use of factorial methods such as PCA and 
MCA complements this approach again in a very visual 
manner.
The way these distinct methodologies complement 
themselves in the result analysis and visualization repre-
sent an added value for understanding results, especially 
for non-statisticians. Using complex and multivariate sta-
tistical methods but obtaining a clear and quite simple 
way of grasping results allows for a swift but more evi-
dence-based decision-making process.
Conceptual path associating policy and health 
allowing for equity
Our third research aim was to propose a conceptual 
quantitative path of analysis to study the association 
between policy and health impacts while taking equity 
into account.
Illustrated by the case study presented in the results 
section, the proposed path starts by analyzing associa-
tions between the policy and the chosen equity issue 
(Figure 5 and SOM Figure 11).
If no association is found between the policy and the 
equity aspect under study, then we could go on analyz-
ing the association between policy and the health event 
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and improve the decision-making process itself (Kemm 
2013).
The HIA approach is thus in an especially good posi-
tion to contribute to health policy future reforms and ‘to 
inform and influence decision-making on proposals and 
plans, so health protection and promotion are effectively 
integrated into them’ (Quigley et al. 2006).
Limitations and future paths for research
Limitations in our research simultaneously represent 
future research opportunities. Some limitations regard 
data used in our case study, which may be tackled and 
enrich future research by:
•  Taking a broader number of patients, for example, 
patients admitted during a longer period of time 
for different diagnosis;
•  Considering hospital readmissions during fol-
low-up for other diagnoses and not only for the 
ones of the first admission;
•  Linking hospital data with more information such 
as PC data after but also before hospital admission, 
prescribed medication, social health determinants, 
health services characteristics, and costs. This is 
coherent with WHO Health 2020 holistic approach 
and also allows deepening complementarities 
between HIA and Health Technology Assessment;
Our HIA approach may thus also strongly contribute 
to evaluating and improving health systems and their 
benchmarking performance, shifting their center from 
providers to people’s individual needs and preferences, 
understanding the impact of policy reform by moving 
from data only related to health activities, inputs and 
costs to information about how people lead their lives 
(such as indicators of comfort and quality of life, ability 
to function and live independently, social and economic 
determinants of health, as well as environmental risk 
factors).
The OECD states the need to further invest in delivery 
models that focus on PC and its coordination with other 
services to assure health promotion and prevention of 
disease. This also represents an opportunity for our HIA-
quantified approach and its practice of analyzing inter-
relations between policies, health determinants, and 
outcomes.
Finally, the strong participatory experience from HIA 
may furthermore help ‘constructive dialogue across gov-
ernments, with industry, and with other key stakehold-
ers including patients, providers, payers and academics’ 
(OECD—Organisation for Economic Co-operation and 
Development 2017). The importance of guaranteeing 
that all stakeholders participate in the decision-mak-
ing process, especially communities affected by poli-
cies under scrutiny, has been recognized to make the 
decision process more open, optimize final decisions 
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Conclusions
When targeting for HIA and EHR policy at PC level 
regarding AMI patients, it is crucial to assure an ade-
quate application of guidelines throughout all health 
regions to minimize regional health inequities. Lessons 
could be learned from regions with lower disparities 
so that actions are to be taken in regions with worse 
performance.
Regional disparities in the application of an EHR pol-
icy targeted for HIA, but also for their association with 
Mortality, may be identified and visualized in a com-
prehensible way for non-statisticians. Evidence-based, 
quantified, multivariate knowledge in an HIA context 
(or even other IA whenever health is an issue) may thus 
improve decision-makers’ understanding of the impor-
tance of taking equity into consideration when assessing 
the health impacts of policies they should take a stand 
on.
The proposed path of analysis to study the associa-
tion between a public policy and related health impacts 
while taking equity into account may be put into practice 
whenever data are available regarding the most relevant 
variables in its particular context. This means that this 
pathway may be helpful to put HIA at the center of future 
health reforms, linking data focused on individuals’ hos-
pital and primary health care usage patterns but also 
healthy lifestyles and environmental information.
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•  Testing our pathway by analyzing other policies 
and public actions, within or outside the health 
sector.
Another potential limitation regards the fact that our pro-
posed pathway studies the association between a public 
policy and its health impacts while taking into account 
an equity aspect and not the impact itself. The existence 
of an association may indeed not infer a causal effect. A 
future challenge is to develop more complex models to 
link longitudinally most relevant aspects in a patients’ 
life, effects of policies over health impacts and equity 
in a big data context and ideally approximately in real 
time. Modeling past and current data over time to better 
predict the health effects in the future may additionally 
consider identifying population risk profiles, increasing 
awareness regarding unexpected equity issues and sup-
plying HIA recommendations differentiated by profiles. 
This may contribute to the need to ‘review our own IA 
strategies, approaches and practices and to adapt them 
to a changing environment, so that we are able to meet 
new challenges’ (Fischer 2017).
A more relevant limitation regards our goal to show 
how the use of the visualization output strengths of these 
methodologies (such as OR graphic representations or 
MCA factorial plans) may represent an added value for 
decision-makers, perhaps making it easier for them to 
comprehend results, more so than other statistical meth-
odologies’ outputs. Although summarizing results in a 
factorial plan may indeed be useful as a representation of 
results obtained, and informally certain decision-makers 
may think it is easier for their understanding of outcomes, 
only a deeper study would demonstrate the higher effec-
tiveness in apprehending conclusions. A survey to a sam-
ple of decision-makers from multiple sectors but with a 
strong emphasis on the health sector based on specific 
tested instruments could contribute to this effect.
Lastly, our proposed pathway suffers potential limita-
tions from being a quantitative HIA approach: chiefly that 
not everything that should be taken into account in HIA 
is quantifiable (Mindell et al. 2001; Fehr et al. 2012, 2016). 
Qualitative HIA approaches should generally comple-
ment quantitative ones. Nevertheless, some qualitative 
aspects may now also increasingly be incorporated into 
quantified models, with the help, for instance, of other 
data mining methodologies such as text mining (Lebart 
and Salem 1994).
These methodologies here used, originating in Data 
Mining and Data Science fields, may also be potentially 
powerful tools to use beyond HIA, to integrate health 
and equity into other impact assessments, such as 
environmental impact assessment or strategic environ-
mental assessment (Fehr et al. 2014) whenever Big Data 
from various sources and natures are to be tackled and 
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